UnknownNot Applicable

AMH, Glucose Intolerance and Metabolic Syndrome in PCOS

Thailand70 participantsStarted 2015-04

Plain-language summary

Association between serum anti-Mullerian hormone (AMH) level and prevalence of glucose intolerance and metabolic syndrome in women with polycystic ovary syndrome (PCOS)

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * PCOS diagnosed by Rotterdam criteria 2003 Exclusion Criteria: * Pregnancy * Previous any hormonal uses in the last 3 months * Previous hypoglycemic drugs or insulin-sensitising agents use in the last 3 months * Previous chemotherapy, ovarian surgery, pelvic irradiation * Menopause

What they're measuring

Differences between serum AMH level between PCOS women with and without glucose intolerance and metabolic syndrome

Timeframe: 6 months

Trial details

NCT IDNCT02676518

SponsorChulalongkorn University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-05

Contact for this trial

Wasamon Tunsuparp, MD

66850658502 wasamontun@gmail.com

View on ClinicalTrials.gov More Polycystic Ovary Syndrome trials